drugset / Trial / NCT01947803
A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With Schizophrenia
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study will be to evaluate the safety and treatment response of paliperidone palmitate administered to Chinese patients with schizophrenia.
Timeline
- Start
- 2013-09
- Primary completion
- 2015-03
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | paliperidone palmitate | Unknown | 75 mg | Intramuscular |
| Subject | paliperidone palmitate | Unknown | 150 mg | Intramuscular |